They found that an activated SHH signaling pathway exists in CD133+ Hepa1-6 HCC cells in mice, with a downregulation of SHH mRNA and an upregulation of SMO mRNA [105]. The gene discussed is SMO; the disease is hepatocellular carcinoma.